BackNeuroSense Therapeutics Overview

NeuroSense Therapeutics Operating Income

Operating Income for NRSN.

Quarterly Operating Income

$-2346000.00
↓ 22.57% YoY

As of Jun 30, 2025

Annual Operating Income (TTM)

$-8570000.00
↓ 29.8% YoY

Trailing 12 months ending Jun 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin